Pharmacokinetics of Tedizolid in Plasma and Sputum of Adults with Cystic Fibrosis

Over the past decade, the prevalence of infections involving methicillin-resistant Staphylococcus aureus (MRSA) in patients with cystic fibrosis (CF) has increased significantly. Tedizolid (TZD) demonstrates excellent activity against MRSA and a favorable safety profile. The pharmacokinetics of seve...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Antimicrob Agents Chemother
Главные авторы: Park, A young J., Wang, Joshua, Jayne, Jordanna, Fukushima, Lynn, Rao, Adupa P., D'Argenio, David Z., Beringer, Paul M.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology 2018
Предметы:
Clinical Therapeutics
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6125567/
https://ncbi.nlm.nih.gov/pubmed/29914949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00550-18
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы